Raxibacumab
NDC 71655-103, raxibacumab, injection, from Emergent BioDefense Operations Lansing.
- Product NDC
- 71655-103
- Status
- Listed
- Labeler
- Emergent BioDefense Operations Lansing
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125349
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71655-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RAXIBACUMAB50 mg/mL
Pharmacologic classes
Anthrax Protective Antigen-directed Antibody Interactions [MoA]; Anthrax Protective Antigen-directed Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71655-103-01 | 71655010301 | 1 VIAL, SINGLE-USE in 1 CARTON (71655-103-01) / 34 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f6927e91-bb46-47b3-ab66-f9d8a9d7b12a
Use it
Look up 71655-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71655-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71655-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.